BR100 Increased By (0.99%)
BR30 Increased By (1.17%)
KSE100 Increased By (0.81%)
KSE30 Increased By (0.77%)
BECO 5.68 Increased By ▲ 0.09 (1.61%)
BML 64.84 Increased By ▲ 3.81 (6.24%)
BOP 33.60 Increased By ▲ 0.35 (1.05%)
CNERGY 8.24 Increased By ▲ 0.19 (2.36%)
DCL 11.35 Increased By ▲ 0.05 (0.44%)
FCCL 52.91 Decreased By ▼ -0.02 (-0.04%)
FCSC 5.52 Increased By ▲ 0.18 (3.37%)
FFL 17.80 Increased By ▲ 0.19 (1.08%)
FNEL 1.30 Decreased By ▼ -0.01 (-0.76%)
HUMNL 11.24 Increased By ▲ 0.12 (1.08%)
KEL 7.97 Increased By ▲ 0.08 (1.01%)
KOSM 5.44 Increased By ▲ 0.11 (2.06%)
MLCF 86.01 Increased By ▲ 0.66 (0.77%)
NBP 185.00 Increased By ▲ 3.71 (2.05%)
PACE 12.02 Increased By ▲ 0.49 (4.25%)
PAEL 40.21 Increased By ▲ 0.80 (2.03%)
PIAHCLA 25.73 Increased By ▲ 0.10 (0.39%)
PIBTL 17.32 Increased By ▲ 0.17 (0.99%)
PPL 225.30 Increased By ▲ 0.48 (0.21%)
PRL 34.38 Increased By ▲ 0.20 (0.59%)
PTC 65.46 Increased By ▲ 0.38 (0.58%)
SEARL 90.51 Increased By ▲ 0.91 (1.02%)
SSGC 26.76 Increased By ▲ 0.45 (1.71%)
TELE 8.96 Increased By ▲ 0.58 (6.92%)
THCCL 69.44 Increased By ▲ 0.10 (0.14%)
TPLP 11.31 Increased By ▲ 1.03 (10.02%)
TREET 24.55 Increased By ▲ 0.35 (1.45%)
TRG 71.67 Increased By ▲ 2.13 (3.06%)
WAVES 11.45 Increased By ▲ 0.42 (3.81%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)

LONDON: Britain's Dan Evans is set to make his comeback after a one-year drugs ban at the Glasgow Trophy ATP Challenger event later this month.

The 27-year-old, who tested positive for cocaine last April, has been handed a wildcard into the qualifying draw for the tournament, which starts on April 28.

"I want to thank everyone who has supported me throughout this difficult period," said Evans. "I have learned a lot about myself in my time away from the game, a sport that I love very dearly.

"I am now committed to training hard, resuming my career and getting back to where I was, although appreciate this will take time."

Evans, who has a career-high ranking of 41, has slipped to 994th in the singles rankings.

 

Copyright AFP (Agence France-Press), 2018
 

 

 

Comments

Comments are closed for this article.